Multiple Pregnancy Failures: An Immunological Paradigm

American Journal of Reproductive Immunology

Volumn 67, Issue 4, 2012, Pages 334-340

  Matthiesen, Leif ^a   Kalkunte, Satyan ^b   Sharma, Surendra ^b  

^a HELSINGBORG HOSPITAL   (Sweden)

^b WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

Human; Immune therapy; Inflammation; Recurrent spontaneous abortion

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; IMMUNOGLOBULIN G; LOW MOLECULAR WEIGHT HEPARIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROGESTERONE; PROTEIN C; PROTEIN S; PROTHROMBIN; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT COLONY STIMULATING FACTOR 1; RECOMBINANT INTERLEUKIN 10;

ANGIOGENESIS; CLINICAL PRACTICE; FERTILIZATION IN VITRO; GENE MUTATION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOREGULATION; IMMUNOTHERAPY; INFERTILITY; INTRAUTERINE GROWTH RETARDATION; LOW DRUG DOSE; LUTEAL INSUFFICIENCY; NIDATION; NONHUMAN; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; RECURRENT DISEASE; RECURRENT SPONTANEOUS ABORTION; REGULATORY T LYMPHOCYTE; REVIEW; SPONTANEOUS ABORTION; T LYMPHOCYTE; UTERUS CAVITY;

ABORTION, HABITUAL; CHORIONIC GONADOTROPIN; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INFANT, NEWBORN; INTERLEUKIN-10; MACROPHAGE COLONY-STIMULATING FACTOR; PREGNANCY; PREGNANCY OUTCOME; T-LYMPHOCYTES, REGULATORY;

EID: 84863402627     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2012.01121.x     Document Type: Review

References (75)

1. Stirrat GM : Recurrent miscarriage: definition and epidemiology. Lancet 1990; 336:673-675.
2. Stirrat GM : Recurrent miscarriage II-Clinical associations, causes, and management. Lancet 1990; 336:728-733.
3. Carrington B, Sacks G, Regan L : Recurrent miscarriage: pathophysiology and outcome. Curr Opin Obstet Gynecol 2005; 17:591-597.
4. Pandey MK, Rani R, Agrawal S : An update in recurrent spontaneous abortion. Arch Gynecol Obstet 2005; 272:95-108.
5. Rai R, Regan L : Recurrent miscarriage. Lancet 2006; 368:601-611.
6. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, De Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA : International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295-306.
7. Goddjin M, Leschot NJ : Parental chromosome testing. In Early Pregnancy. RG Farquharson, MD Stephenson (eds). Cambridge, Cambridge University Press, 2010, pp 91-102.
8. Royal College of Obstetricians and Gynecologist (RCOG). The investigation and treatment of couples with recurrent spontaneous miscarriage. Guidelines no 17. May 2003. 1-13.
9. Redecha P, Tilley R, Tencati M, Salmon JE, Kirchhofer D, Mackman N, Girardi G : Tissue factor: a link between C5a and neutrophile activation in antiphospholipid antibody-induced fetal injury. Blood 2007; 110:2423-2431.
10. Ticconi C, Giuliani E, Veglia M, Pietropolli A, Piccione E, Di Simone N : Thyroid autoimmunity and recurrent miscarriage. Am J Reprod Immunol 2011; 66:452-459.
11. Thangaratinam S, Tan A, Kilby MD : Thyroid autoimmunity and recurrent miscarriage. BMJ 2011; 342:d2616. doi:10.1136/bmj.d2616.
12. Kuperman A, Micco PD, Brenner B : Fertility, infertility and thrombophilia. Women′s Health 2011; 7:545-553.
13. Wegmann TG, Lin H, Guilbert L, Mossmann TR : Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14:353-356.
14. Clark DA, Arck PC, Chaouat G : Why did your mother reject you? Immunogenetic determinants of the response to environmental selective pressure expressed at the uterine level. Am J Reprod Immunol 1999; 41:5-22.
15. Thellin O, Coumans B, Zorzi W, Igout A, Heinen E : Tolerance to the foeto-placental graft: ten ways to support a child for nine months. Curr Opin Immunol 2000; 12:731-737.
16. Levi M, van der Poll T : Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med 2005; 15:254-259.
17. Li M, Huang J : Innate immunity, coagulation and placenta -related adverse pregnancy outcomes. Thromb Res 2009; 124:656-662.
18. Jauniaux E, Farquharson RG, Christiansen OB, Exalto N : Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod 2006; 21:2216-2222.
19. Van Den Boogaard E, Hermens RP, Leschot NJ, Baron R, Vollebergh JH, Bernardus RE, Van Der Veen F, Kremer JA, Goddijn M : Identification of barriers for good adherence to a guideline on recurrent miscarriage. Acta Obstet Gynecol Scand 2011; 90:186-191.
20. Porter TF, Scott JR : Evidence-based care of recurrent miscarriage. Best Pract Res Clin Obstet Gynecol 2005; 19:85-101.
21. Stephenson M, Kutteh W : Evaluation and management of recurrent early pregnancy loss. Clin Obstet Gynecol 2007; 50:132-145.
22. Norwich ER, Schust DJ, Fisher SJ : Implantation and the survival of early pregnancy. NEJM 2001; 345:1400-1408.
23. Moffett-King A : Natural Killer cells and pregnancy. Nat Rev 2002; 2:656-663.
24. Karimi K, Blois SM, Arck PC : The upside of natural killers. Nat Med 2008; 14:1184-1185.
25. Bischof P, Campana A : A model for implantation of the human blastocyst and early placentation. Hum Reprod Update 1996; 2:262-270.
26. Red-Horse K, Zhou Y, Genbacev O, Prakobphol A, Foulk R, McMaster M, Fisher SJ : Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest 2004; 114:744-754.
27. Kalkunte S, Lai Z, Tewari N, Chichester C, Romero R, Padbury J, Sharma S : In-vitro and in-vivo evidence for lack of endovascular remodelling by third trimester trophoblasts. Placenta 2008; 29:871-878.
28. Kalkunte S, Boij R, Norris W, Friedman J, Lai Z, Kurtis J, Lim KH, Padbury JF, Matthiesen L, Sharma S : Serum from preeclampsia patients elicits symptoms of human disease in mice and provides a basis for an in vitro predictive assay. Am J Pathol 2010; 177:2387-2397.
29. Aluvihara VR, Kallikourdis M, Betz AG : Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5:266-271.
30. + regulatory T cells in human pregnancy: development of a Treg-MLC-ELISPOT suppression assay and indications of paternal specific Tregs. Immunology 2007; 120:456-466.
31. Kalkunte S, Mselle TF, Norris WE, Wira CR, Sentman CL, Sharma S : Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface. J Immunol 2009; 182:4085-4092.
32. Kwak-Kim J, Yang KM, Gilman-Sachs A : Recurrent pregnancy loss: a disease of inflammation and coagulation. J Obstet Gynecol Res 2009; 35:609-622.
33. Rai R, Backos M, Baxter N, Chilcott I, Regan L : Recurrent miscarriage - an aspirin a day? Hum Reprod 2000; 15:2220-2223.
34. Dolitzky M, Inbal A, Segal Y, Weiss A, Brenner B, Carp H : A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertil Steril 2006; 86:362-366.
35. Badawy AM, Khiary M, Sherif LS, Hassan M, Ragab A, Abdelall I : Low-molecular weight heparin in patients with recurrent early miscarriages of unknown etiology. Obstet Gynecol 2008; 28:280-284.
36. Fawzy M, Shokeir T, El-Tatongy M, Warda O, El-Refaiey AA, Mosbah A : Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study. Arch Gynecol Obstet 2008; 278:33-38.
37. Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA, Kingdom JC, Barrett J, Gent M : Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA trial. J Rheumatol 2009; 36:279-287.
38. Kaandorp SP, Goddijn M, van der Post JA, Hutten BA, Verhoeve HR, Hamulyák K, Mol BW, Folkeringa N, Nahuis M, Papatsonis DN, Büller HR, van der Veen F, Middeldorp S : Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010; 362:1586-1596.
39. Clark P, Walker ID, Langhorne P, Crichton L, Thomson A, Greaves M, Whyte S, Greer IA : Scottish Pregnancy Intervention Study (SPIN) collaborators: SPIN (Scottish pregnancy intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood 2010; 115:4162-4167.
40. Visser J, Ulander VM, Helmerhorst FM, Lampinen K, Morin-Papunen L, Bloemenkamp KW, Kaaja RJ : Thromboprophylaxis for recurrent miscarriage in women with and without thrombophilia. HABENOX: a randomised muliticentre trial. Thromb Haemost 2011; 105:295-301.
41. Mantha S, Bauer KA, Zwicker JI : Low molecular weight heparin to achieve live birth following unexplained pregnancy loss: a systemic review. J Thromb Haemost 2010; 8:263-268.
42. Schusts DJ, Andelin CO : Immunology of isolated and recurrent spontaneous pregnancy loss. Glob Libr Women′s Med 2008; ISSN: 1756-2228; DOI 10.3843/GLOWM.10320.
43. Bajekal N, Li TC : Fibroids, infertility and pregnancy wastage. Hum Reprod Update 2000; 6:614-620.
44. Salim R, Woelfer B, Backos M, Regan L, Jurkovic D : Reproducibility of three dimensional ultrasound diagnosis of congenital uterine anomalies. Ultrasound Obstet Gynecol 2003; 21:578-582.
45. Farquharson RG, QUenby S, Greaves M : Antiphospholipid syndrome in pregnancy: a randomized, conrolled trial of treatment. Obstet Gynecol 2002; 100:408-413.
46. Empson M, Lassere M, Craig JC, Scott JR : Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2005; 2:1-75. CD002859.
47. Middeldorp S, Goddjin M : Recurrent miscarriage and thrombophilia. Dutch Med J 2006; 150:189-193.
48. Ball E, Robson SC, Ayis S, Lyall F, Bulmer JN : Early embryonic demise: no evidence of abnormal spiral artery transformation on trophoblast invasion. J Pathol 2006; 208:528-534.
49. Ball E, Bulmer JN, Ayis S, Lyall F, Robson SC : Late sporadic miscarriage is associated with abnormalities in spiral artery transformation and trophoblast invasion. J Pathol 2006; 208:535-542.
50. Quenby S, Mountfield S, Cartwright JE, Whitley GS, Vince G : Effects of Low-Molecular-Weight and unfractionated heparin on trophoblast function. Obstet Gynecol 2004; 104:354-361.
51. Nelson SM, Greer IA : The potential role of heparin in assisted conception. Hum Reprod Update 2008; 14:623-645.
52. Laskin CA, Bombardier C, Hannah ME, Mandel FP, Ritchie JW, Farewell V, Farine D, Spitzer K, Fielding L, Soloninka CA, Yeung M : Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 1997; 337:148-153.
53. Choi BC, Polgar K, Xiao L, Hill JA : Progesterone inhibit in-vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod 2000; 15(Suppl 1):46-59.
54. Haas DM, Ramsey PS : Progesterone for preventing miscarriage. Cochrane Database Syst Rev 2008; 2:1-37. CD003511.
55. Dwyer JM : Manipulating the immune system with immune globulin. N Engl J Med 1992; 326:107-116.
56. Thornton CA, Ballow M : Safety of intravenous immunoglobulin. Arch Neurol 1993; 50:135-136.
57. Coulam CB, Krysa L, Stern JJ, Bustillo M : Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol 1995; 34:333-337.
58. Christiansen OB : Intravenous immunoglobulin in the prevention of recurrent spontaneous abortion: the European experience. Am J Reprod Immunol 1998; 39:77-81.
59. Stephenson MD, Dreher K, Houlihan E, Wu V : Prevention of recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, double-blinded, placebo-controlled trial. Am J Reprod Immunol 1998; 39:82-88.
60. Sjöblom C, Wikland M, Robertson SA : GM-CSF acts independently of the beta common subunit of the GM-CSF receptor to prevent inner cell mass apoptosis in human embryos. Biol Reprod 2002; 67:1817-1823.
61. Shapiro BS, Richter KS, Daneshmand ST, Quinn P, Behr B : GM-CSF enhances human embryo development to the blastocyst stage: a randomized study. Fertil Steril 2003; 79(Suppl 2):15-16.
62. Segerer S, Kammerer U, Kapp M, Dietl J, Rieger L : Upregulation of chemokine and cytokine production during pregnancy. Obstet Gynecol Invest 2009; 67:145-150.
63. Perricone R, De Carolis C, Giacomelli R, Guarino MD, De Sanctis G, Fontana L : GM-CSF and pregnancy: concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment. Am J Reprod Immunol 2003; 50:232-237.
64. Scarpelini F, Sbracia M : Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum Reprod 2009; 24:2703-2708.
65. Scott JR, Pattison N : Human chorionic gonadotropin for recurrent miscarriage. Cochrane Database Syst Rev 2005; 2:1-10. CD000101.
66. Schumacher A, Brachwitz N, Sohr S, Engeland K, Langwisch S, Dolaptchieva M, Alexander T, Taran A, Malfertheiner SF, Costa SD, Zimmermann G, Nitschke C, Volk HD, Alexander H, Gunzer M, Zenclussen AC : Human chorionic gonadotropin attracts regulatory T cells into the fetal-matemal interface during early human pregnancy. J Immunol 2009; 182:5488-5497.
67. Norris W, Nevers T, Sharma S, Kalkunte S : Review: hCG, preeclampsia and regulatory T cells. Placenta 2011; 32(Suppl 2):S182-S185.
68. Wiwanitkit V : Predictive value of human chorionic gonadotrophin in the outcome of early pregnancy achieved by assisted reproductive technology: a summative assessment. J Hum Reprod Sci 2010; 3:161.
69. Rudensky A : Regulatory T cells get their chance to shine. Science 2011; 332:1020-1021.
70. + regulatory T cells after lymphocyte therapy in unexplained recurrent spontaneous abortion patients. Fertil Steril 2009; 92:301-305.
71. Milojevic D, Nguyen KD, Wara D, Mellins ED : Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development. Pediatr Rheumatol 2008; 6:1-13.20.
72. Lidström C, Matthiesen LS, Berg G, Sharma S, Ernerudh J, Ekerfelt C : Cytokines secretion patterns of NK cells and macrophages in early human pregnant decidua and blood: implications for suppressor macrophages in decidua. Am J Reprod Immunol 2003; 50:444-452.
73. Svensson J, Jenmalm MC, Matussek A, Geffers R, Berg G, Ernerudh J : Macrophages at the maternal fetal interface express markers of alternative activation and are induced by M-CSF and IL-10. J Immunol 2011; 187:3671-3682.
74. Hamilton JA : Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008; 8:533-544.
75. Mosser DM, Zhang X : Interleukin-10: a new perspective of an old cytokine. Immunol Rev 2008; 226:205-218.